BioTek Instruments, Inc. Develops Automation Technology to Aid in Blood...

BioTek Instruments, Inc. Develops Automation Technology to Aid in Blood Banking Tests

BioTek Instruments, a leader in microplate instrumentation technology, has developed in partnership with Immucor, Inc. (Norcross, GA), an automated benchtop assay instrument for use in the blood transfusion industry. Manufactured by BioTek exclusively for Immucor, the Galileo® Echo™ provides small- to medium-sized hospital blood bank laboratories with walk-away automation of tests such as ABO grouping and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing and red blood cell phenotyping for significant increases in productivity and patient safety while taking less time than other methods.

The Galileo Echo instrument was recently cleared by the FDA for marketing in the United States, and also received a CE mark, along with its associated reagents, for distribution in Europe. "Immucor and BioTek have forged a strong partnership for over fifteen years, which is key to producing beneficial products that seamlessly fuse our respective skills and expertise," noted Adam Alpert, Vice President of BioTek Instruments. "We congratulate Immucor on the recent clearance of the Galileo Echo system, and we look forward to the results of our mutually successful projects."

BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. The BioTek Instruments, Inc. instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.

Founded in 1982, Immucor, Inc. manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of their market segments.